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transmitral Doppler flow velocity as measure of LV filling 
pressure (r = − 0.52, p < 0.001) and tricuspid regurgita-
tion flow velocity as measure of pulmonary artery pres-
sure (r = − 0.38, p = 0.001). RVEF was significantly worse 
in patients with dilated cardiomyopathy compared with 
ischaemic heart disease: median 48 % (interquartile range 
(IQR) 37–55 %) versus 56 % (IQR 48–63 %), p < 0.05.
Conclusions In patients with dilated cardiomyopathy and 
ischaemic heart disease, RV function is determined by 
LV systolic and diastolic function, the underlying cause 
of LV dysfunction, and pulmonary artery pressure. It was 
demonstrated that RV function is more impaired in dilated 
cardiomyopathy.
Introduction
Right ventricular (RV) dysfunction and dilatation are corre-
lated to limited exercise capacity and poor outcome [1–4], 
but often neglected in the clinical setting [5, 6]. Dilated 
cardiomyopathy (DCM) and ischaemic heart disease (IHD) 
can both lead to RV dysfunction. Direct comparisons of 
the two entities with respect to RV size and function using 
state-of-the-art imaging techniques have not yet been per-
formed. Such a comparison may help to better understand 
the underlying pathophysiology of RV dysfunction. There-
fore, we determined RV function and volume in relation 
to left ventricular (LV) systolic and diastolic function, and 
pulmonary artery pressure in patients with DCM to assess 
the main mechanisms of RV dysfunction. In addition, after 
matching for LV ejection fraction (LVEF), patients with 
IHD due to infarction of the left coronary artery were also 
examined.
Abstract
Background Dilated cardiomyopathy and ischaemic heart 
disease can both lead to right ventricular (RV) dysfunction. 
Direct comparisons of the two entities regarding RV size 
and function using state-of-the-art imaging techniques have 
not yet been performed. We aimed to determine RV func-
tion and volume in dilated cardiomyopathy and ischaemic 
heart disease in relation to left ventricular (LV) systolic and 
diastolic function and systolic pulmonary artery pressure.
Methods and results A well-characterised group (cardiac 
magnetic resonance imaging, echocardiography, coronary 
angiography and endomyocardial biopsy) of 46 patients with 
dilated cardiomyopathy was compared with LV ejection 
fraction (EF)-matched patients (n = 23) with ischaemic heart 
disease. Volumes and EF were determined with magnetic 
resonance imaging, diastolic LV function and pulmonary 
artery pressure with echocardiography.
After multivariable linear regression, four factors inde-
pendently influenced RVEF (R2 = 0.51, p < 0.001): LVEF 
(r = 0.54, p < 0.001), ratio of peak early and peak atrial 
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Methods
Study population
Two groups of patients were included in the study: patients 
with DCM from Maastricht University Medical Center and 
patients with IHD from our infarct database matched for 
LVEF.
Study subjects in the DCM group comprised 46 consecu-
tive patients with DCM referred to our heart failure program. 
All underwent a standard diagnostic evaluation including 
electrocardiogram (ECG), coronary angiography, endomyo-
cardial biopsy, echocardiography and cardiac magnetic res-
onance imaging (CMR). LV and RV volumes and systolic 
function were determined by CMR. LV diastolic function 
and RV systolic pressure were assessed with echocardiog-
raphy as described later in the text. Patients with a history 
of myocardial infarction, history of cardiotoxic agents, sig-
nificant coronary artery stenosis on coronary angiography, 
valvular heart disease on echocardiography as well as other 
known causes of impaired systolic function such as inflam-
mation or infiltrative disorders on endomyocardial biopsy 
were excluded from the study. Patients with permanent 
pacemakers, rhythm other than sinus and significant chronic 
renal failure ( ≥ stage 3 kidney disease) were also excluded.
Study subjects in the IHD group were included from our 
infarct database matched for LVEF as measured by CMR. 
Thus, 23 patients with impaired systolic LV function due to 
chronic non-inferior myocardial infarction (infarction in left 
anterior descending (LAD) or left circumflex (LCX) coronary 
artery territory to avoid inclusion of patients with RV infarc-
tion) and without significant valvular disease were included. 
The study was approved by the local ethics committee.
Magnetic resonance imaging
Patients were examined with a 1.5-T scanner (Gyroscan 
Intera,Philips Medical Systems, Best, the Netherlands). 
ECG-gatedcine images were acquired for functional analy-
sis using a steady-state free precession sequence (slice thick-
ness 6 mm, gap 4 mm, repetition time/echo time 3.8/1.9 ms, 
flip angle 50°, field of view 350 mm, matrix 256 × 256, 
22–25 phases per cardiac cycle). A breath-hold multislice 
T1-weighted three-dimensional inversion-recovery gradi-
ent-echo sequence (acquired/reconstructed slice thickness 
12/6 mm, average repetition time/echo time 3.9/2.4 ms, 
multi-shot [50 profiles/shot] segmented partial echo read-
out, flip angle 15°, field of view 400 mm, matrix 256 × 256) 
to evaluate the presence of myocardial infarction of the left 
and right ventricle was used to acquire images 10 min after 
intravenous administration of 0.2 mmol/kg body weight 
gadolinium diethylenetriaminepentaacetic acid (Magnevist, 
Bayer, Germany). Inversion times were adjusted to null nor-
mal myocardium (200–280 ms).
CMR images were analysed by an investigator blinded 
to clinical and echocardiographic data. Endocardial and 
epicardial LV and endocardial RV contours were manually 
traced in end-diastolic and end-systolic phases on short-axis 
slices to determine LV and RV end-diastolic volume (EDV), 
end-systolic volume (ESV), ejection fraction (EF) and LV 
end-diastolic mass. Areas of late enhancement were visually 
assessed to confirm the presence and extent of infarction in 
the LAD or LCX territory as the reason for impaired LVEF 
in the IHD group.
Echocardiography
Echocardiography was used to determine LV diastolic func-
tion, LA volume and peak tricuspid regurgitation (TI) Dop-
pler velocity. Transthoracic echocardiograms were performed 
using dedicated systems (Sonos 5500 with S3 or IE33 with 
S5-1 transducers, Philips Medical Systems, Andover, MA, 
USA). Echocardiographic investigations were performed in 
the standard views, according to the recommendations of the 
American Society of Echocardiography [7]. LV diastolic func-
tion was assessed by measuring mitral (ratio of peak early and 
peak atrial transmitral Doppler flow velocity, E/A) and pulmo-
nary vein flow velocities (ratio of peak systolic and diastolic 
pulmonary vein Doppler flow velocity, S/D), tissue Doppler 
flow velocities from the basal septal and lateral wall to cal-
culate the ratio of early transmitral inflow and myocardial 
tissue velocity (E/e’) and left atrial (LA) volumes. Since we 
did not include patients with normal LV function, we used the 
E/A ratio as an easily obtainable measure of LV filling pres-
sure. Peak tricuspid regurgitation (TI) Doppler flow velocity 
was used as a measure of pulmonary artery systolic pressure 
(PAP). Images were digitally stored and analysed off-line by 
an investigator blinded to CMR results and clinical data.
Statistical analysis
Variables are expressed as percentage, mean ± standard 
deviation or median (interquartile range (IQR)) as appro-
priate. The Kolmogorov–Smirnov test was applied to test 
whether continuous variables were normally distributed. 
Group comparisons were performed by using the Pearson 
χ2 test, Student’s t-test or Mann–Whitney U test, as appro-
priate. For correlations, Pearson’s r was used. Finally, inde-
pendent variables influencing RVEF were sought by using 
the multivariable linear regression model with a backward 
procedure (inclusion p < 0.05, exclusion p < 0.1).
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Table 1 Clinical, cardiac magnetic resonance imaging and echocardiographic characteristics of the patients with dilated cardiomyopathy (DCM) 
and ischaemic heart disease (IHD)
Characteristic DCM (n = 46) IHD (n = 23) p Value
Age, years 49 ± 14 59 ± 16 < 0.01
Male, n (%) 27 (59 %) 18 (78 %) 0.18
Body surface area, m2 1.92 ± 0.25 1.97 ± 0.19 0.28
Dyspnoea 0.48
 NYHA 1/2, n (%) 38 (83 %) 21 (91 %)
 NYHA 3/4, n (%) 8 (17 %) 2 (9 %)
Duration HF, months 4 (1–18) 3 (0–19) 0.98
Diabetes mellitus 0.62
 Type 1, n (%) 1 (2 %) 0 (0 %)
 Type 2, n (%) 4 (9 %) 1 (4 %)
COPD, n (%) 6 (13 %) 2 (9 %) 0.71
Hypertension, n (%) 9 (18 %) 8 (35 %) 0.24
 Systolic BP 125 ± 20 123 ± 19 0.80
 Diastolic BP 75 ± 12 74 ± 10 0.75
Heart rate, beats/min 77 ± 14 73 ± 13 0.32
PR duration, ms 150 ± 57 157 ± 60 0.66
QRS duration, ms 111 ± 31 92 ± 43 0.10
LBBB, n (%) 16 (35 %) 4 (17 %) 0.17
RBBB, n (%) 0 (0 %) 2 (9 %) 0.11
Creatinine, µmol/l 92 ± 27 95 ± 45 0.74
Beta-blocker 36 (78 %) 18 (78 %) 0.34
ACE-inhibitor or AT-II-receptor blocker 40 (87 %) 21 (91 %) 0.20
Diuretic 32 (70 %) 9 (39 %) 0.03
Aldosterone antagonist 12 (26 %) 4 (17 %) 0.28
Calcium channel blocker 0 (0 %) 1 (4 %) 0.13
RV EDV, ml/m2 78 (65–92) 71 (63–78) 0.03
RV ESV, ml/m2 41 (35–51) 32 (24–39) 0.03
RV SV, ml/m2 35 (28–43) 38 (29–43) 0.98
RVEF, % 48 (37–55) 56 (48–63) 0.05
LV EDV, ml/m2 120 (96–158) 131 (101–165) 0.79
LV ESV, ml/m2 82 (64–117) 85 (66–128) 0.63
LV SV, ml/m2 39 (29–46) 38 (34–43) 0.75
LVEF, % 31 (22–40) 34 (18–39) 0.77
LV mass, g/m2 75 (62–84) 68 (62–86) 0.86
RA volume, ml/m2 20 (16–32) 22 (17–26) 0.43
LA volume, ml/m2 32 (26–53) 37 (28–46) 0.86
E max velocity, cm/s 71 (55–82) 68 (53–98) 0.67
E/A 1.00 (0.70–1.40) 0.96 (0.63–1.78) 0.99
dt E-top ms 170 (130–205) 160 (130–220) 0.68
S/D 1.04 (0.81–1.33) 1.00 (0.62–1.45) 0.79
E/e’ IVS 10.0 (8.0–13.0) 6.5 (4.9–7.5) < 0.001
E/e’ 7.7 (5.4–9.7) 8.4 (6.6–11.5) 0.31
TI peak velocity, m/s 2.13 (1.86–2.44) 2.42 (2.02–3.03) 0.04
Values represent mean ± standard deviation, median (interquartile range) or n, numbers of patients (%)
DCM dilated cardiomyopathy, IHD ischaemic heart disease, NYHA New York Heart Association class, COPD chronic obstructive pulmonary 
disease, HF heart failure, BP blood pressure, LBBB left bundle branch block, RBBB right bundle branch block, ACE angiotensin converting 
enzyme, AT II angiotensin II, RV right ventricular, LV left ventricular, EDV end-diastolic volume, ESV end-systolic volume, SV stroke volume, 
EF ejection fraction, PASP pulmonary artery systolic pressure, RA right atrial, LA left atrial, E peak early transmitral Doppler flow velocity, E/A 
ratio of peak early and peak atrial transmitral Doppler flow velocity, dt E-top deceleration time of peak early transmitral Doppler flow signal, 
S/D ratio of peak systolic and diastolic pulmonary vein Doppler flow velocity, E/e’ IVS ratio of peak early transmitral Doppler flow velocity 
and peak early diastolic tissue Doppler flow velocity from the basal septal left ventricular wall, E/e’ ratio of peak early transmitral Doppler 
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patients with DCM had focal fibrosis of the RV free wall 
myocardium on CMR late enhancement images.
RV volume and function
Differences between patients with DCM and IHD
The RVEF was more impaired and RV size larger in 
patients with DCM in comparison with patients with IHD 
(Figs. 3 and 4) despite similar LV systolic and diastolic 
dysfunction. There was an isolated increase in E/e’ of the 
septum in DCM patients, but an opposite trend laterally 
and no further differences were seen in diastolic parameters 
between the groups, suggesting no difference in diastolic 
LV function. LV EDV and ESV were not different between 
the groups. All CMR and echocardiography parameters are 
summarised in Table 1.
Parameters influencing RV function
As depicted in Table 2, the RVEF was significantly cor-
related with LVEF and the volumes of all four cardiac 
chambers. Furthermore, parameters of LV diastolic func-
Results
Clinical characteristics of patients with DCM and IHD
The clinical characteristics of the DCM and IHD patients 
are summarised in Table 1. Patients in the IHD group were 
older and less often treated with diuretics. All other param-
eters were not significantly different between the groups.
CMR image analysis was possible in all patients. In three 
patients, however, image quality on echocardiography was 
not sufficient to obtain reliable pulmonary vein flow Dop-
pler signals. In two of them, image quality was also not suf-
ficient to obtain tissue Doppler signals, but the E/A ratio 
could be determined in all patients.
A total of 21 patients with IHD had infarcts in the 
LAD territory and 2 patients in the LAD and LCX terri-
tory (Fig. 1). Infarction of the RV free wall was recognised 
in only one patient of the IHD group: a small area of late 
enhancement of the RV apex was visible on CMR images. 
This patient had a transmural infarction in the LAD territory 
showing late enhancement from the anterior wall to the apex 
of the LV continuing to the RV apex (Fig. 2). None of the 
Fig. 1 Late gadolinium enhance-
ment (a, b) and cine (four-cham-
ber view in end-diastole (c) and 
end-systole (d)) magnetic reso-
nance images of a patient with a 
large myocardial infarction (left 
ventricular ejection fraction 15 %) 
of the left anterior descending 
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RV function and volumes. RV systolic function was influ-
enced by different factors including the underlying disease 
process, i.e. the presence of DCM, systolic and diastolic 
function of the LV and elevation of the PAP.
In ST-segment elevation myocardial infarction (STEMI) 
patients with cardiogenic shock, RV dysfunction had been 
identified as a prognostic parameter [8]. Between patients 
with and without RV dysfunction, no significant differences 
in infarct-related artery and infarct location were observed. 
RV dysfunction in patients in whom the right coronary artery 
(RCA) was not the infarct-related artery was also present. 
This suggests that not only direct RV infarction causes RV 
dysfunction but also mechanisms such as reduced blood 
supply of the septum, low RV preload due to low output 
and diminished contribution of LV contraction to RV systole 
[8]. RV function may depend on LV septal contractile con-
tribution transmitted through systolic ventricular interaction 
[9–11] and the septum itself may contribute to the systolic 
function of both ventricles [12]. RV function was experi-
mentally as much impaired with septal ligation as with 
RCA ligation [13]. Our results, however, suggest that other 
factors such as elevated LV filling pressure and PAP are of 
additional importance to explain reduced RV function.
tion negatively correlated with RV function. Also, the TI 
velocity as measure of PAP was negatively correlated with 
RVEF. Finally, age and heart rate showed significant corre-
lations with RVEF. RVEF was higher in women compared 
with men (55 ± 10 versus 44 ± 13 %, p = 0.001). Other clini-
cal parameters had no influence on RVEF (data not shown). 
Overall, there were no significant differences in these cor-
relations between patients with DCM and IHD (data not 
shown).
Multivariable analysis revealed that the RV function (i.e. 
RVEF) was correlated with LVEF, DCM compared with 
IHD, E/A ratio as measure of LV filling pressure, and TI 
velocity as measure of PAP as depicted in Table 3. Although 
the relationship with TI velocity was of borderline signifi-
cance, it was in addition to a measure of LV filling pressure, 
e.g. a possible active process in addition to passive elevation 
of PAP due to elevated LV filling pressures.
Discussion
In the current study, the non-invasive imaging techniques 
CMR and echocardiography were applied in patients with 
DCM and IHD without RV free wall infarction, to evaluate 
Fig. 2 Late gadolinium enhance-
ment (four-chamber view (a), 2 
chamber view (b)) and cine (four-
chamber view in end-diastole (c) 
and end-systole (d)) magnetic 
resonance images of a patient 
with a large myocardial infarction 
(left ventricular ejection fraction 
22 %) of the left anterior descend-
ing coronary artery, continuing 
from the left ventricular apex to 
the right ventricle (right ventricu-
lar ejection fraction 57 %) (white 
arrow) A corresponding akinetic 
region of the right ventricular 
apex can be depicted on the 
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risk for necrosis, although the resulting final RV infarction 
size was small. A possible explanation for the discrepancy 
between this and our findings is that only a small portion of 
our patients had transmural infarcts of the whole septum.
The underlying process also determines RV function. 
Patients with DCM experienced larger RV volumes and more 
severe impairment of RV function. In contrast to previous 
suggestions [19, 20], assessing systolic RV function alone is 
not sufficient to distinguish between DCM and IHD in indi-
vidual patients. Few studies have directly compared the RV 
function in patients with DCM and IHD. Our findings are 
supported by some earlier studies where patients with DCM 
showed more severe RV dysfunction than patients with 
IHD using radionuclide angiography, thermodilution and 
invasive RV angiography [19–21]. However, these findings 
have not been uniform. By applying tissue Doppler imag-
ing, the RV dysfunction was more pronounced in patients 
with IHD than DCM in an echocardiographic study [22]. 
Since only two patients had inferior wall infarction based 
on ECG criteria, the authors concluded that this worse RV 
function had not been due to more infarcted RV myocar-
dium. However, patients were not sufficiently matched with 
respect to other factors potentially influencing RV function. 
Thus, patients with IHD exhibited more severe LV diastolic 
RV infarction detected by late enhancement CMR and 
RV systolic function were outcome predictors in a general 
population of STEMI patients [14]. In inferior STEMI, RV 
systolic function was related to the presence and extent of 
RV infarction, while in anterior STEMI it was related to LV 
systolic dysfunction. When imaging more early after infarc-
tion, RV infarction was not related to prognosis [15]. This 
discrepancy could be explained by the fact that RV function 
may recover to a greater extent than LV function, depend-
ing on recovery of septal function [9]. Thus, global RV per-
formance recovered within days after infarction, regardless 
of artery patency [16]. Moreover, global RV performance 
improved greatly even in chronic RCA occlusion, despite 
persistent severe RV free wall dysfunction [17]. To exclude 
the influence of direct RV free wall infarct on RV function, 
we included only patients with infarcts of the left coronary 
artery territory (LAD and LCX infarct). To our knowledge, 
this has not been applied in previous comparative studies of 
patients with DCM and IHD. We observed a small exten-
sion of infarct from the left to the RV myocardium in one 
patient only, which is in some contrast to a recent CMR 
study in 20 patients with reperfused proximal LAD occlu-
sion where a small RV infarct was observed in 40 % of the 
patients [18]. They found a relatively large area of the RV at 
Fig. 3 Late gadolinium enhance-
ment (a, b) and cine (four-
chamber view in end-diastole (c) 
and end-systole (d)) magnetic 
resonance images of a patient 
with idiopathic dilated cardiomy-
opathy (left ventricular ejection 
fraction 24 %, right ventricular 
ejection fraction 45 %) The left 
ventricular systolic function of 
this patient is slightly better than 
that of the patients with ischaemic 
heart disease from Figs. 1 and 2 
while the right ventricular func-
tion is more impaired. Areas of 
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RV dysfunction. Moreover, assessment of RV dimensions 
and systolic function by echocardiography has important 
limitations. In the present study, we therefore used the cur-
rent reference standard CMR to assess RV volumes and EF 
[6, 23, 24].
Elevated LV filling pressure, which leads to passive ele-
vation of PAP, was one of the factors related to RV dysfunc-
tion in the current study. Since the prognosis of patients with 
impaired RV function is worse in comparison with patients 
with impaired systolic LV function only [25, 26], assess-
ment of RV function and possibly more aggressive treatment 
dysfunction and higher PAP. Such a difference in PAP and 
diastolic function was not present in our patient groups, but 
PAP and diastolic function were independently related to 
Fig. 4 Late gadolinium enhance-
ment (a, b) and cine (four-
chamber view in end-diastole (c) 
and end-systole (d)) magnetic 
resonance images of a patient 
with idiopathic dilated cardio-
myopathy with more pronounced 
dilation of the right ventricle (left 
ventricular ejection fraction 36 %, 
end-diastolic volume 211 ml; 
right ventricular ejection frac-
tion 23 %, end-diastolic volume 
269 ml) Although elevated left 
ventricular filling pressure and TI 
velocity were present, the degree 
of right ventricular dilation is out 
of proportion, possibly suggesting 
an active unknown process affect-
ing the right ventricle more than 
the left ventricle
 
Table 2 Correlations of clinical, cardiac magnetic resonance imaging 
(CMR) and echocardiographic characteristics with right ventricular 
ejection fraction as measured with CMR
Variable Correlation p Value
Age 0.29 0.02
Systolic BP 0.13 0.28
HR − 0.46 < 0.001
LVEF 0.54 < 0.001
LV EDV − 0.29 0.02
RV EDV − 0.50 < 0.001
LA volume − 0.41 < 0.001
RA volume − 0.37 < 0.001
E/A ratio − 0.52 < 0.001
S/D ratio 0.48 < 0.001
TI velocity − 0.38 0.001
BP blood pressure, HR heart rate, LV left ventricular, RV right 
ventricular, EF ejection fraction, EDV end-diastolic volume, LA 
left atrial, RA right atrial, E/A ratio of peak early and peak atrial 
transmitral Doppler flow velocity, S/D ratio of peak systolic and 
diastolic pulmonary vein Doppler flow velocity, TI peak tricuspid 
regurgitation Doppler flow velocity
Table 3 Regression analysis testing the association between right ven-
tricular ejection fraction and various potential predictors in the entire 
study population (dilated cardiomyopathy and ischaemic heart disease)
Variable Regression coefficient p Value
LVEF (per %) 0.50 < 0.0001
DCM versus IHD 9.41 0.0005
E/A ratio (per unit) − 3.60 0.02
TI velocity (per m/s) − 4.84 0.06
(R2 = 0.51)
DCM dilated cardiomyopathy, IHD ischaemic heart disease, 
LVEF left ventricular ejection fraction, E/A ratio of peak early and 
peak atrial transmitral Doppler flow velocity, TI peak tricuspid 
regurgitation Doppler flow velocity
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of elevated LV filling pressure as suggested by Stevenson 
et al. [27] might be important, irrespective of the underly-
ing cause. An additional active component of elevated pul-
monary artery pressure, i.e. out-of-proportion pulmonary 
hypertension leading to fixed pulmonary hypertension, may 
also have contributed to worsening of RV function since 
elevated PAP was related to RV dysfunction independently 
of LV filling pressure.
The current study has some limitations. Patients in the 
IHD group were older and less often treated with diuretics. 
Older age had a negative influence on RV function. How-
ever, although the patients in the IHD group were older, they 
showed a less impaired RV function than the patients from 
the DCM group. Thus, not matching for age did not result 
in a relevant bias. Treatment with diuretics can lower LV 
filling pressure and PAP and might have had an influence on 
the lower TI peak velocity measured in patients with DCM 
[28]. In contrast to IHD, DCM usually comprises a hetero-
geneous group of diseases in many studies. However, with 
a comprehensive diagnostic routine including endomyocar-
dial biopsy, imaging and blood tests, certain diseases such 
as acute myocarditis, infiltrative and storage diseases were 
excluded from our study to make the DCM study popula-
tion as uniform as possible. Regional RV wall motion as 
measured by, e.g. speckle tracking was not assessed. Early 
stages of dyssynchronicity between the right and left ventri-
cle were therefore not detected. Other potential mechanisms 
were also not addressed, e.g. interventricular interaction and 
effects of changes of geometry. Finally, this was a diagnos-
tic study. However, the study revealed different potential 
mechanisms of RV dysfunction that may be therapeutically 
influenced. It is important to evaluate RV function, espe-
cially in DCM, and it may be necessary to treat elevated 
filling pressure and PAP more aggressively or with new 
therapeutic strategies such as phosphodiesterase inhibitors 
to protect the right ventricle.
In conclusion, RV systolic function was influenced by 
different factors including the underlying disease process, 
i.e. the presence of DCM, systolic and diastolic function 
of the LV and elevation of PAP. A better understanding of 
these mechanisms may help to define therapeutic targets for 
future studies in these patients with RV dysfunction known 
to have a poor outcome.
Funding None.
Compliance with ethical guidelines
Conflict of interest None declared.
This study was approved by the Medical Ethics Committee of the 
Maastricht University Medical Center, Maastricht, the Netherlands.
240
1 3
Neth Heart J (2015) 23:232–240
24. Quick S, Speiser U, Kury K, et al. Evaluation and classification of 
right ventricular wall motion abnormalities in healthy subjects by 
3-tesla cardiovascular magnetic resonance imaging. Neth Heart J. 
2015;23:64–9.
25. Ghio S, Gavazzi A, Campana C, et al. Independent and additive 
prognostic value of right ventricular systolic function and pulmo-
nary artery pressure in patients with chronic heart failure. J Am 
Coll Cardiol. 2001;37:183–8.
26. Zornoff LA, Skali H, Pfeffer MA, et al. Right ventricular dysfunc-
tion and risk of heart failure and mortality after myocardial infarc-
tion. J Am Coll Cardiol. 2002;39:1450–5.
27. Stevenson LW, Dracup KA, Tillisch JH. Efficacy of medical 
therapy tailored for severe congestive heart failure in patients 
transferred for urgent cardiac transplantation. Am J Cardiol. 
1989;63:461–4.
28. Stampfer M, Epstein SE, Beiser GD, et al. Hemodynamic effects 
of diuresis at rest and during intense upright exercise in patients 
with impaired cardiac function. Circulation. 1968;37:900–11.
18. Bodi V, Sanchis J, Mainar L, et al. Right ventricular involvement 
in anterior myocardial infarction: a translational approach. Cardio-
vasc Res. 2010;87:601–8.
19. Iskandrian AS, Helfeld H, Lemlek J, et al. Differentiation be-
tween primary dilated cardiomyopathy and ischemic cardio-
myopathy based on right ventricular performance. Am Heart J. 
1992;123:768–73.
20. La Vecchia L, Zanolla L, Varotto L, et al. Reduced right ventricular 
ejection fraction as a marker for idiopathic dilated cardiomyopathy 
compared with ischemic left ventricular dysfunction. Am Heart J. 
2001;142:181–9.
21. Juilliere Y, Buffet P, Marie PY, et al. Comparison of right ven-
tricular systolic function in idiopathic dilated cardiomyopathy and 
healed anterior wall myocardial infarction associated with athero-
sclerotic coronary artery disease. Am J Cardiol. 1994;73:588–90.
22. Parcharidou DG, Giannakoulas G, Efthimiadis GK, et al. Right 
ventricular function in ischemic or idiopathic dilated cardiomy-
opathy. Circ J. 2008;72:238–44.
23. Doesch C, Zompolou C, Streitner F, et al. CMR-derived TAPSE 
measurement: a semi-quantitative method of right ventricular 
function assessment in patients with hypertrophic cardiomyopa-
thy. Neth Heart J. 2014;22:557–64.
